Stratos Genomics raises $20M from Fisk Ventures to commercialize SBX nanopore DNA sequencing, total funding tops $50M
Stratos Genomics raised $20 million from Fisk Ventures to finalize commercialization of its Sequencing By Expansion (SBX) nanopore-based DNA sequencing technology, bringing total funding to over $50 million. The company says SBX is faster, cheaper and highly accurate, aiming to enter healthcare, research, agriculture and biotech markets within the coming year.